SCHEMBL6174018

SCHEMBL6174018

CCCCOC(=O)Nc1cc(C(C)C2NC(=O)N(c3ccc(OC(F)(F)F)cc3)C2=O)ccn1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC5A1 P13866 5/20 0.36
LIPE Q05469 1/20 0.35
PDE2A O00408 4/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPK1 P28482 1/20 0.34
LMNA P02545 1/20 0.34
CBLB Q13191 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
SYK P43405 1/20 0.33
NTRK1 P04629 1/20 0.33
IGF1R P08069 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172737 0.93 MAPK1 (0.37) SLC5A1PDE2AL3MBTL1MAPK1LMNA
SCHEMBL6175310 0.91 MCHR1 (0.35) SLC5A1PDE2AMAPK1LMNACBLB
SCHEMBL6175093 0.89 IGF1R (0.44) PDE2ANPC1HPGDRAB9ASMN1; SMN2
SCHEMBL6172454 0.89 GAA (0.36) NPC1HPGDRAB9ASMN1; SMN2L3MBTL1
SCHEMBL6173626 0.88 SLC5A1 (0.37) SLC5A1PDE2AMAPK1LMNACBLB
SCHEMBL6171770 0.86 LMNA (0.43) SLC5A1PDE2AMAPK1LMNACBLB
SCHEMBL6172084 0.83 LMNA (0.40) SLC5A1PDE2AL3MBTL1MAPK1LMNA
SCHEMBL6174274 0.83 GCGR (0.42) SLC5A1LIPEPDE2ANPC1RAB9A
SCHEMBL6177704 0.83 KDR (0.42) SLC5A1
SCHEMBL6173730 0.83 IDH1 (0.42) NPC1RAB9AMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed